At the start of this week, several of the top managers at allergy firm ALK exercised their rights to buy shares in the company. They have since sold these shares again, resulting in substantial profits, an internal memo reveals.
CEO Carsten Hellmann made two transactions. One of those involved exercising his options and purchasing 86,692 shares at DKK 41.12 (USD 5.8) per share, spending a total of DKK 3,564,775 (USD 503,221).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and partner Abbvie in the second half of this year.
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
The Danish Medicines Agency has been told for the second time that the price of the obesity drug is not in line with the effect it provides.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Coloplast's climate goals approved by international initiative
The Science Based Targets initiative has approved Coloplast’s carbon emission reduction goals.
Top news from MedWatch this week
Miss anything?
Director Regulatory Affairs 
Senior Toxicologist 
Principal Laboratory Technologist Medicinal Chemistry 
Scientific Writer 
Senior Teaching Fellow for the BioMedical Design Novo Nordisk Foundation Fellowship Program 
Device Associate Director/Senior Project Leader 
Chair of the Board 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Specialist within CMC, Regulatory Affairs Life Cycle Management 
KLIFO is looking for a Clinical Trial Assistant for our office in Glostrup, Lund or Münich 
Global Product Manager - ENT 
Project Managers keep all of us healthy